Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sarepta Therapeutics, Inc.
With
Hoffmann-La Roche
Age
Any age
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Received delandistrogene moxeparvovec for Duchenne muscular dystrophy in a previous clinical study.
Has (a) parent(s) or legal caregiver(s) or is ≥18 years of age and able to understand and comply with the study visit schedule and all other protocol requirements.
